COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,004 Articles (21,508 medRxiv, 7,496 bioRxiv)

Most recent first Previous |  Page 2568: Articles 25671-25680  | Next

Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2
Lapuente, D., Maier, C., Irrgang, P., Huebner, J., Peter, S. A., Hoffmann, M., Ensser, A., Ziegler, K., Winkler, T. H., Birkholz, T., Kremer, A. E., Steininger, P., Korn, K., Neipel, F., Ueberla, K., Tenbusch, M.
10.1101/2020.05.09.20091447 — Posted: 2020-05-13 Discussion: Onsite
Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcome
Ramlall, V., Thangaraj, P., Tatonetti, N. P., Shapira, S. D.
10.1101/2020.05.05.20092452 — Posted: 2020-05-13 Discussion: Onsite | Offsite
Beneficial effect of corticosteroids in severe COVID-19 pneumonia: a propensity score matching analysis.
Chroboczek, T., Lacoste, M., Wackenheim, C., Challan-Belval, T., Amar, B., Boisson, T., Hubac, J., Leduc, D., Masse, C., Dechaene, V., Touhiri-Maximin, L., Megessier, S., Lassale, C.
10.1101/2020.05.08.20094755 — Posted: 2020-05-13 Discussion: Onsite
Origin of Novel Coronavirus (COVID-19): A Computational Biology Study using Artificial Intelligence
Nguyen, T. T., Abdelrazek, M., Nguyen, D. T., Aryal, S., Nguyen, D. T., Khatami, A.
10.1101/2020.05.12.091397 — Posted: 2020-05-13
An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets
Ward, D., Higgins, M., Phelan, J., Hibberd, M. L., Campino, S., Clark, T. G.
10.1101/2020.05.11.089409 — Posted: 2020-05-13
Meta-analysis of transcriptomes of SARS-Cov2 infected human lung epithelial cells identifies transmembrane serine proteases co-expressed with ACE2 and biological processes related to viral entry, immunity, inflammation and cellular stress.
Wruck, W., Adjaye, J.
10.1101/2020.05.12.091314 — Posted: 2020-05-13
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells: Nafamostat is the most potent antiviral drug candidate
Ko, M., Jeon, S., Ryu, W.-S., Kim, S.
10.1101/2020.05.12.090035 — Posted: 2020-05-12
Mutation landscape of SARS-CoV-2 reveals three mutually exclusive clusters of leading and trailing single nucleotide substitutions
Mishra, A., Pandey, A. K., Gupta, P., Pradhan, P., Dhamija, S., Gomes, J., Kundu, B., Vivekanandan, P., Menon, M. B.
10.1101/2020.05.07.082768 — Posted: 2020-05-12
Androgen regulates SARS-CoV-2 receptor levels and is associated with severe COVID-19 symptoms in men
Ghazizadeh, Z., Majd, H., Richter, M., Samuel, R., Zekavat, S. M., Asgharian, H., Farahvashi, S., Kalantari, A., Ramirez, J., Zhao, H., Natarajan, P., Goodarzi, H., Fattahi, F.
10.1101/2020.05.12.091082 — Posted: 2020-05-12 Discussion: Onsite | Offsite
Children's Hospital Los Angeles COVID-19 Analysis Research Database (CARD) - A Resource for Rapid SARS-CoV-2 Genome Identification Using Interactive Online Phylogenetic Tools
Shen, L., Maglinte, D., Ostrow, D., Pandey, U., Bootwalla, M., Ryutov, A., Govindarajan, A., Ruble, D., Han, J., Triche, T. J., Dien Bard, J., Biegel, J. A., Judkins, A. R., Gai, X.
10.1101/2020.05.11.089763 — Posted: 2020-05-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).